Profile data is unavailable for this security.
About the company
Dr. Martens plc is a United Kingdom-based company, which designs, develops, procures, markets, sells and distributes footwear, under the Dr. Martens brand. The Company’s segments include Europe, the Middle East and Africa (EMEA); Americas; and Americas and Asia-Pacific (APAC). Its product segments include boots, shoes, sandals, and bags & other. Its boots offerings include the 1460 8-eye boot, 2976 Chelsea boot, Jadon, Bex and Sinclair. Its shoes offerings include 1461 3-eye shoe and the Adrian tassel loafer, as well as franchises/families such as Buzz and Lowell. Its sandals range includes Blaire and Gryphon silhouettes and also includes the mules range, led by the Zebzag. Its bag range is focused on key silhouettes of leather bags, such as the Kiev backpack, the heart-shaped bag and its weekender bag. This category also includes socks, laces and shoe care. The Company offers its products through direct-to-consumer channel via its ecommerce platforms and its stores, among others.
- Revenue in GBP (TTM)785.00m
- Net income in GBP15.30m
- Incorporated2020
- Employees2.35k
- LocationDr Martens PLC28 Jamestown Rd, CamdenLONDON NW1 7BYUnited KingdomGBR
- Websitehttps://www.drmartensplc.com/
| Holder | Shares | % Held |
|---|---|---|
| Morgan Stanley Smith Barney LLC (Investment Management)as of 01 Jan 2026 | 370.04m | 38.26% |
| Artemis Investment Management LLPas of 20 Nov 2025 | 107.08m | 11.07% |
| HSBC Private Bank (UK) Ltd.as of 01 Jan 2026 | 56.08m | 5.80% |
| Royal London Asset Management Ltd.as of 01 Jan 2026 | 39.79m | 4.11% |
| BlackRock Investment Management (UK) Ltd.as of 30 Mar 2025 | 34.79m | 3.60% |
| Fidelity Management & Research Co. LLCas of 01 Jan 2026 | 33.20m | 3.43% |
| Franklin Mutual Advisers LLCas of 01 Jan 2026 | 32.84m | 3.40% |
| GIC Pte Ltd. (Investment Management)as of 30 Mar 2025 | 28.84m | 2.98% |
| The Vanguard Group, Inc.as of 01 Jan 2026 | 15.69m | 1.62% |
| Ninety One UK Ltd.as of 01 Jan 2026 | 14.27m | 1.48% |
